Table 5.

Response

CR  
0  
PR   1 (CR criteria met except marrow hypocellular)  
Significant clinical benefit   7/20 (35%)* 
50% PB blast reduction   14/20 (70%)† 
Total
 		 14/20 (70%)
 
CR  
0  
PR   1 (CR criteria met except marrow hypocellular)  
Significant clinical benefit   7/20 (35%)* 
50% PB blast reduction   14/20 (70%)† 
Total
 		 14/20 (70%)
 

PB indicates peripheral blood.

*

Includes the patient with a PR.

†

Includes significant clinical benefit (significant clinical benefit defined as ≥ 2 log reductions in peripheral blasts for at least 4 weeks).

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal